Skip to content

Targeting the Medial Prefrontal Cortex with High-Definition Transcranial Direct Current Stimulation for Chronic Disorders of Consciousness: A Randomized Double-Blind Sham-Controlled Crossover Trial

Targeting the Medial Prefrontal Cortex with High-Definition Transcranial Direct Current Stimulation for Chronic Disorders of Consciousness: A Randomized Double-Blind Sham-Controlled Crossover Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128948
Enrollment
Unknown
Registered
2026-07-28
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic consciousness disorder

Interventions

Active-first / Sham-second sequence:Active-first / Sham-second sequence-HD-tDCS
Sham-first / Active-second sequence:Sham-first / Active-second sequence- HD-tDCS

Sponsors

The Fifth Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis: CRS-R score indicates consciousness level of UWS/VS or MCS, meeting clinical diagnostic criteria for chronic disorders of consciousness; 2.Age: 16-80 years; 3.Legal representative of the patient voluntarily participates after reading the informed consent form;

Exclusion criteria

Exclusion criteria: 1.History of primary epilepsy or refractory epilepsy secondary to brain injury; 2.History of cranioplasty in the frontal region, especially with severe scalp collapse; 3.History of cranioplasty in the frontal region, especially with severe scalp collapse; 4.Use of sedative drugs within 24 hours prior to EEG recording or behavioral assessment; 5.Unstable acute medical complications at enrollment, including uncontrolled severe systemic infection, hyperthermia, acute respiratory failure, sympathetic storm, etc. 6.Consciousness disorders caused by specific toxic metabolic encephalopathy such as carbon monoxide poisoning; 7.Comorbidity of severe underlying diseases such as malignant tumors, with expected survival of less than 6 months;

Design outcomes

Primary

MeasureTime frame
Behavioral Assessment;

Secondary

MeasureTime frame
Electroencephalogram indicators;

Countries

China

Contacts

Public ContactZhang Min

The Fifth Affiliated Hospital of Zhengzhou University

zhangmin93@126.com+86 10 12345678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026